Background Genome-wide association studies (GWAS) in Parkinson's disease have increased
the scope of biological knowledge about the disease over the past decade. We aimed to …

With recent findings connecting the Epstein-Barr virus to an increased risk of multiple sclerosis
and growing concerns regarding the neurological impact of the coronavirus pandemic, …

A substantial proportion of risk for Parkinson's disease (PD) is driven by genetics. Progress
in understanding the genetic basis of PD has been significant. So far, highly-penetrant rare …

Background Increasing evidence supports an extensive and complex genetic contribution to
PD. Previous genome‐wide association studies (GWAS) have shed light on the genetic …

The genetic basis of Lewy body dementia (LBD) is not well understood. Here, we performed
whole-genome sequencing in large cohorts of LBD cases and neurologically healthy …

Background Type 2 diabetes (T2DM) and Parkinson's disease (PD) are prevalent diseases
that affect an aging population. Previous systematic reviews and meta‐analyses have …

Importance Substantial genome-wide association study (GWAS) work in Parkinson disease (PD)
has led to the discovery of an increasing number of loci shown reliably to be associated …

Objective To identify shared polygenic risk and causal associations in amyotrophic lateral
sclerosis (ALS). Methods Linkage disequilibrium score regression and Mendelian …

In the past two decades, mutations in multiple genes have been linked to autosomal dominant
or recessive forms of monogenic Parkinson’s disease (PD). Collectively, these monogenic …

Parkinson’s disease is a genetically complex disorder. Multiple genes have been shown to
contribute to the risk of Parkinson’s disease, and currently 90 independent risk variants have …